Search Results - "Murat, O"

The non‐haematopoietic biological effects of erythropoietin by Arcasoy, Murat O.

“…Summary In the haematopoietic system, the principal function of erythropoietin (Epo) is the regulation of red blood cell production, mediated by its specific…”
Get full text

Arterial thrombosis and second cancer in MPNs by Arcasoy, Murat O.

Get full text

The effect of ultrasound on particle size, color, viscosity and polyphenol oxidase activity of diluted avocado puree by Bi, Xiufang, Hemar, Yacine, Balaban, Murat O., Liao, Xiaojun

“…•Ultrasound treatment of defatted avocado puree significantly decreased particle size.•Viscosity increased significantly.•Measured PPO activity increased by…”
Get full text

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea by Yacoub, Abdulraheem, Mascarenhas, John, Kosiorek, Heidi, Prchal, Josef T., Berenzon, Dmitry, Baer, Maria R., Ritchie, Ellen, Silver, Richard T., Kessler, Craig, Winton, Elliott, Finazzi, Maria Chiara, Rambaldi, Alessandro, Vannucchi, Alessandro M., Leibowitz, David, Rondelli, Damiano, Arcasoy, Murat O., Catchatourian, Rosalind, Vadakara, Joseph, Rosti, Vittorio, Hexner, Elizabeth, Kremyanskaya, Marina, Sandy, Lonette, Tripodi, Joseph, Najfeld, Vesna, Farnoud, Noushin, Papaemmanuil, Elli, Salama, Mohamed, Singer-Weinberg, Rona, Rampal, Raajit, Goldberg, Judith D., Barbui, Tiziano, Mesa, Ruben, Dueck, Amylou C., Hoffman, Ronald

“…Prior studies have reported high response rates with recombinant interferon-α (rIFN-α) therapy in patients with essential thrombocythemia (ET) and polycythemia…”
Get full text

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis by Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael, Miller, Carole, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Koumenis, Iphigenia L, Sun, William, Sandor, Victor, Kantarjian, Hagop M

“…This trial showed clinically significant responses in spleen size and quality of life among patients with myelofibrosis receiving ruxolitinib, a JAK1 and JAK2…”
Get full text

ZCCHC8 , the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation by Gable, Dustin L, Gaysinskaya, Valeriya, Atik, Christine C, Talbot, Jr, C Conover, Kang, Byunghak, Stanley, Susan E, Pugh, Elizabeth W, Amat-Codina, Nuria, Schenk, Kara M, Arcasoy, Murat O, Brayton, Cory, Florea, Liliana, Armanios, Mary

“…Short telomere syndromes manifest as familial idiopathic pulmonary fibrosis; they are the most common premature aging disorders. We used genome-wide linkage to…”
Get full text

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial by Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop

“…The randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial evaluated the JAK1/JAK2 inhibitor ruxolitinib in patients with…”
Get full text

Color of rainbow trout (Oncorhynchus mykiss) fillets by image and sensory analysis, and correlation with SalmoFan numbers by Gümüş, Bahar, Gümüş, Erkan, Balaban, Murat O.

“…A total of 72 male and 50 female trout (Oncorhynchus mykiss) fillets were weighed (range 328–794 g, mean 546.2 ± 101.8 g; and range 426–994 g, mean…”
Get full text

Comparison of three image‐analysis‐based visual texture calculation methods: energy, entropy, and texture change index by Balaban, Murat O, Gümüş, Bahar, Gümüş, Erkan

“…BACKGROUND Three image analysis methods to measure visual texture were applied to an image with much texture (scaled carp), and one with little texture (mirror…”
Get full text

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I by Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Raza, Azra, Vaddi, Kris, Sun, William, Peng, Wei, Sandor, Victor, Kantarjian, Hagop

“…In the phase III COMFORT-I study, the Janus kinase 1 (JAK1)/JAK2 inhibitor ruxolitinib provided significant improvements in splenomegaly, key symptoms, and…”
Get full text

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer by RIZZO, J. Douglas, BROUWERS, Melissa, JAKUBOWSKI, Ann A, REGAN, David H, SOMERFIELD, Mark R, HURLEY, Patricia, SEIDENFELD, Jerome, ARCASOY, Murat O, SPIVAK, Jerry L, BENNETT, Charles L, BOHLIUS, Julia, EVANCHUK, Darren, GOODE, Matthew J

“…To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients…”
Get full text

Review of dense phase CO2 technology: microbial and enzyme inactivation, and effects on food quality by Damar, S, Balaban, M.O

“…Dense phase CO2 (DPCD) is a non-thermal technology that can inactivate certain microorganisms and enzymes at temperatures low enough to avoid the thermal…”
Get full text

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia by Mascarenhas, John, Kosiorek, Heidi E., Prchal, Josef T., Rambaldi, Alessandro, Berenzon, Dmitriy, Yacoub, Abdulraheem, Harrison, Claire N., McMullin, Mary Frances, Vannucchi, Alessandro M., Ewing, Joanne, O'Connell, Casey L., Kiladjian, Jean-Jacques, Mead, Adam J., Winton, Elliott F., Leibowitz, David S., De Stefano, Valerio, Arcasoy, Murat O., Kessler, Craig M., Catchatourian, Rosalind, Rondelli, Damiano, Silver, Richard T., Bacigalupo, Andrea, Nagler, Arnon, Kremyanskaya, Marina, Levine, Max F., Arango Ossa, Juan E., McGovern, Erin, Sandy, Lonette, Salama, Mohamad E., Najfeld, Vesna, Tripodi, Joseph, Farnoud, Noushin, Penson, Alexander V., Weinberg, Rona Singer, Price, Leah, Goldberg, Judith D., Barbui, Tiziano, Marchioli, Roberto, Tognoni, Gianni, Rampal, Raajit K., Mesa, Ruben A., Dueck, Amylou C., Hoffman, Ronald

“…The goal of therapy for patients with essential thrombocythemia (ET) and polycythemia vera (PV) is to reduce thrombotic events by normalizing blood counts…”
Get full text

Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasms by El Bitar, Sandy, Arcasoy, Murat O

“…The treatment landscape for BCR/ABL-negative myeloproliferative neoplasms (MPNs), driven by and mutations, has evolved significantly over the last decade…”
Get full text

Enhanced photovoltaic panel energy by minichannel cooler and natural geothermal system by Jafari, Rahim, Erkılıç, Kaan T., Uğurer, Doruk, Kanbur, Yunus, Yıldız, Murat Ö., Ayhan, Ege B.

“…Summary Commercial photovoltaic (PV) solar panels convert the solar energy directly to electricity but their efficiency is low. The rest of the energy is…”
Get full text

The clinical and laboratory evaluation of the patient with erythrocytosis by Lee, Grace, Arcasoy, Murat O

“…Abstract Erythrocytosis is frequently encountered as an incidental abnormality on laboratory testing that reveals persistent elevation of the hematocrit level…”
Get full text

Electronic Structure Study of Ni-B Alloy Coatings by XAFS Technique by Murat Özkendir, O., Cengiz, Erhan, Hakkı Karahan, I., Klysubun, Wantana

“…The crystal and electronic structure properties of Ni-B (nickel-boron) alloy coatings produced by an electrodeposition method have been investigated. The…”
Get full text

Effect of high pressure processing and cooking treatment on the quality of Atlantic salmon by Yagiz, Yavuz, Kristinsson, Hordur G., Balaban, Murat O., Welt, Bruce A., Ralat, Maria, Marshall, Maruice R.

“…The effect of high pressure treatment (HPP) (150 MPa and 300 MPa for 15 min) and cooking on quality of Atlantic salmon based on microbial activity, lipid…”
Get full text

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis by SILHAN, Leann L, SHAH, Pali D, ARCASOY, Murat O, ARMANIOS, Mary, CHAMBERS, Daniel C, SNYDER, Laurie D, RIISE, Gerdt C, WAGNER, Christa L, HELLSTRÖM-LINDBERG, Eva, ORENS, Jonathan B, MEWTON, Juliette F, DANOFF, Sonye K

“…Lung transplantation is the only intervention that prolongs survival in idiopathic pulmonary fibrosis (IPF). Telomerase mutations are the most common…”
Get full text

Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I by Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Paquette, Ronald, Raza, Azra, Vaddi, Kris, Erickson-Viitanen, Susan, Sun, William, Sandor, Victor, Kantarjian, Hagop M

“…COMFORT-I is a randomized, double-blind, placebo-controlled trial of the Janus kinase 1/Janus kinase 2 inhibitor ruxolitinib in 309 patients with…”
Get full text